Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Carcinoma × vistusertib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Stomach Neoplasms 2 Solid Tumor 2 Neoplasms 2 Triple Negative Breast Neoplasms 1 Small Cell Lung Carcinoma 1 Recurrence 1 Prostatic Neoplasms 1 Non-small Cell Lung Cancer Metastatic 1 Meningioma 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma 1 Lung Neoplasms 1 Estrogen Receptor Positive Breast Cancer 1 Endometrial Neoplasms 1 Disease 1 Carcinoma, Squamous Cell 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma 1 Breast Neoplasms 1 Advanced Cancer 1 Adenocarcinoma 1

Interventions

Cisplatin 17 Gemcitabine 15 pembrolizumab 14 Radiotherapy 13 Paclitaxel 13 Radiotherapy, Intensity-Modulated 12 Carboplatin 10 Cyclophosphamide 9 Cetuximab 8 Magnetic Resonance Spectroscopy 7 Specimen Handling 6 Oxaliplatin 6 Fluorouracil 6 Docetaxel 6 Capecitabine 6 padeliporfin 5 Radiation 5 Irinotecan 5 Drug Therapy 5 poly ICLC 4 fludarabine 4 anlotinib 4 Standard of Care 4 Nivolumab 4 Leucovorin 4 Ipilimumab 4 Celecoxib 4 durvalumab 3 Sunitinib 3 Sorafenib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02730923 2024-02-13

VICTORIA

Centre Leon Berard

Phase 1/2 Unknown

Carcinoma, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡